Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
Senti Biosciences Granted US Patent #12005081 For "Chimeric Receptors And Methods Of Use For Acute Myeloid Leukemia Cancer Antigen Targets" Today
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.